How Long Does Carbamazepine Take to Work for Trigeminal Neuralgia
1. Adams F, editor. The extant works of Aretaeus, the Cappadocian. London (UK): Sydenhem Society; 1856. [Google Scholar]
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9–160. [PubMed] [Google Scholar]
3. Childs AM, Meaney JF, Ferrie CD, Holland PC. Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports. Arch Dis Child. 2000;82:311–315. [PMC free article] [PubMed] [Google Scholar]
4. Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008;137:681–688. [PubMed] [Google Scholar]
5. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC. Incidence of facial pain in the general population. Pain. 2009;147:122–127. [PubMed] [Google Scholar]
6. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology. 1991;10:276–281. [PubMed] [Google Scholar]
7. Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study 2002-2005. BMC Fam Pract. 2008;9:26. [PMC free article] [PubMed] [Google Scholar]
8. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;3:CD005451. [PubMed] [Google Scholar]
10. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev. 2011;1:CD005451. [PMC free article] [PubMed] [Google Scholar]
11. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71:1183–1190. [PubMed] [Google Scholar]
12. Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain. 2002;18:4–13. [PubMed] [Google Scholar]
14. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124:2347–2360. [PubMed] [Google Scholar]
15. Hassan S, Khan NI, Sherwani OA, Bhatt W, Asif S. Trigeminal neuralgia: an overview of literature with emphasis on medical management. Int Research J Pharmcol. 2013;3:235–238. [Google Scholar]
16. El Otmani H, Moutaouakil F, Fadel H, Slassi I. [Familial trigeminal neuralgia] Rev Neurol (Paris) 2008;164:384–387. French. [PubMed] [Google Scholar]
17. Ali FM, Prasant M, Pai D, Aher VA, Kar S, Safiya T. Peripheral neurectomies: A treatment option for trigeminal neuralgia in rural practice. J Neurosci Rural Pract. 2012;3:152–157. [PMC free article] [PubMed] [Google Scholar]
18. Cruccu G, Truini A. Refractory trigeminal neuralgia. Non-surgical treatment options. CNS Drugs. 2013;27:91–96. [PubMed] [Google Scholar]
19. Nurmikko TJ, Eldridge PR. Trigeminal neuralgia--pathophysiology, diagnosis and current treatment. Br J Anaesth. 2001;87:117–132. [PubMed] [Google Scholar]
20. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013–1028. [PubMed] [Google Scholar]
21. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;3:CD001133. [PubMed] [Google Scholar]
22. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev. 2005;3:CD005452. [PubMed] [Google Scholar]
23. Zakrzewska JM, Lopez BC. Trigeminal neuralgia. Clin Evid. 2005;14:1669–1677. [PubMed] [Google Scholar]
24. Granger P, Biton B, Faure C, Vige X, Depoortere H, Graham D, et al. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol. 1995;47:1189–1196. [PubMed] [Google Scholar]
25. Joffroy A, Levivier M, Massager N. Trigeminal neuralgia. Pathophysiology and treatment. Acta Neurol Belg. 2001;101:20–25. [PubMed] [Google Scholar]
27. Devor M, Wood I, Sharav Y, Zakrzewska JM. Trigeminal neuralgia during sleep. Pain Pract. 2008;8:263–268. [PubMed] [Google Scholar]
28. Ferrell PB, Jr, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics. 2008;9:1543–1546. [PMC free article] [PubMed] [Google Scholar]
29. George M, Selvarajan S, Indumathi C. Drug therapy for trigeminal neuralgia. e-Journal of Dentistry. 2011;1:28–31. [Google Scholar]
30. Martinez W, Ingenito A, Blakeslee M, Barkley GL, McCague K, D'Souza J. Efficacy, safety, and tolerability of oxcarbazepine monotherapy. Epilepsy Behav. 2006;9:448–456. [PubMed] [Google Scholar]
31. Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy. 2000;20:152S–158S. [PubMed] [Google Scholar]
32. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–244. [PubMed] [Google Scholar]
33. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46:960–963. [PubMed] [Google Scholar]
34. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223–230. [PubMed] [Google Scholar]
35. Lunardi G, Leandri M, Albano C, Cultrera S, Fracassi M, Rubino V, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48:1714–1717. [PubMed] [Google Scholar]
36. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2007;2:CD006044. [PubMed] [Google Scholar]
37. Fromm GH, Terrence CF, Chattha AS, Glass JD. Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nucleus: a pilot study. Arch Neurol. 1980;37:768–771. [PubMed] [Google Scholar]
38. Parekh S, Shah K, Kotdawalla H. Baclofen in carbamazepine resistant trigeminal neuralgia - a double-blind clinical trial. Cephalalgia. 1989;9:392–393. [Google Scholar]
39. Leandri M. Therapy of trigeminal neuralgia secondary to multiple sclerosis. Expert Rev Neurother. 2003;3:661–671. [PubMed] [Google Scholar]
40. Zakrzewska JM. Medical management of trigeminal neuropathic pains. Expert Opin Pharmacother. 2010;11:1239–1254. [PubMed] [Google Scholar]
41. Cheshire WP., Jr Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain. 2002;3:137–142. [PubMed] [Google Scholar]
42. Serpell MG Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557–566. [PubMed] [Google Scholar]
43. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 1998;51:611–614. [PubMed] [Google Scholar]
44. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther. 2003;25:81–104. [PubMed] [Google Scholar]
45. Rodríguez MJ, Díaz S, Vera-Llonch M, Dukes E, Rejas J. Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. Curr Med Res Opin. 2007;23:2585–2596. [PubMed] [Google Scholar]
46. Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28:174–181. [PubMed] [Google Scholar]
47. Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr. 2007;65:792–794. [PubMed] [Google Scholar]
48. Wang QP, Bai M. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis. CNS Drugs. 2011;25:847–857. [PubMed] [Google Scholar]
49. Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16:740–744. [PubMed] [Google Scholar]
50. Mitsikostas DD, Pantes GV, H Avramidis TG, Karageorgiou KE, Gatzonis SD, Stathis PG, et al. An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. Headache. 2010;50:1371–1377. [PubMed] [Google Scholar]
51. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68:402–408. [PubMed] [Google Scholar]
52. Frampton JE. OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine. Drugs. 2012;72:825–845. [PubMed] [Google Scholar]
54. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26:785–793. [PubMed] [Google Scholar]
55. Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, et al. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain. 2013;14:72. [PMC free article] [PubMed] [Google Scholar]
56. Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32:443–450. [PubMed] [Google Scholar]
57. Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65:1306–1308. [PubMed] [Google Scholar]
58. Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, et al. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:47–50. [PubMed] [Google Scholar]
59. Zúñiga C, Díaz S, Piedimonte F, Micheli F. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr. 2008;66:500–503. [PubMed] [Google Scholar]
60. Türk U, Ilhan S, Alp R, Sur H. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol. 2005;28:161–162. [PubMed] [Google Scholar]
61. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002;3:21–27. [PubMed] [Google Scholar]
62. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg. 1999;89:985–988. [PubMed] [Google Scholar]
63. Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manage. 2001;21:506–510. [PubMed] [Google Scholar]
64. Kanai A, Suzuki A, Kobayashi M, Hoka S. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97:559–563. [PubMed] [Google Scholar]
65. Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46:577–582. discussion 583-584. [PubMed] [Google Scholar]
66. Yang M, Zhou M, He L, Chen N, Zakrzewska JM. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. 2011;1:CD004029. [PubMed] [Google Scholar]
67. Hodaie M, Coello AF. Advances in the management of trigeminal neuralgia. J Neurosurg Sci. 2013;57:13–21. [PubMed] [Google Scholar]
68. Pollock BE. Surgical management of medically refractory trigeminal neuralgia. Curr Neurol Neurosci Rep. 2012;12:125–131. [PubMed] [Google Scholar]
69. Bohnstedt BN, Tubbs RS, Cohen-Gadol AA. The use of intraoperative navigation for percutaneous procedures at the skull base including a difficult-to-access foramen ovale. Neurosurgery. 2012;70:177–180. [PubMed] [Google Scholar]
70. Udupi BP, Chouhan RS, Dash HH, Bithal PK, Prabhakar H. Comparative evaluation of percutaneous retrogasserian glycerol rhizolysis and radiofrequency thermocoagulation techniques in the management of trigeminal neuralgia. Neurosurgery. 2012;70:407–412. discussion 412-413. [PubMed] [Google Scholar]
71. Koopman JS, de Vries LM, Dieleman JP, Huygen FJ, Stricker BH, Sturkenboom MC. A nationwide study of three invasive treatments for trigeminal neuralgia. Pain. 2011;152:507–513. [PubMed] [Google Scholar]
72. Gorgulho AA, De Salles AA. Impact of radiosurgery on the surgical treatment of trigeminal neuralgia. Surg Neurol. 2006;66:350–356. [PubMed] [Google Scholar]
73. Sheehan J, Pan HC, Stroila M, Steiner L. Gamma knife surgery for trigeminal neuralgia: outcomes and prognostic factors. J Neurosurg. 2005;102:434–441. [PubMed] [Google Scholar]
74. Petit JH, Herman JM, Nagda S, DiBiase SJ, Chin LS. Radiosurgical treatment of trigeminal neuralgia: evaluating quality of life and treatment outcomes. Int J Radiat Oncol Biol Phys. 2003;56:1147–1153. [PubMed] [Google Scholar]
75. Régis J, Metellus P, Hayashi M, Roussel P, Donnet A, Bille-Turc F. Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia. J Neurosurg. 2006;104:913–924. [PubMed] [Google Scholar]
76. Lopez BC, Hamlyn PJ, Zakrzewska JM. Stereotactic radiosurgery for primary trigeminal neuralgia: state of the evidence and recommendations for future reports. J Neurol Neurosurg Psychiatry. 2004;75:1019–1024. [PMC free article] [PubMed] [Google Scholar]
77. Kondziolka D, Zorro O, Lobato-Polo J, Kano H, Flannery TJ, Flickinger JC, et al. Gamma Knife stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg. 2010;112:758–765. [PubMed] [Google Scholar]
How Long Does Carbamazepine Take to Work for Trigeminal Neuralgia
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727618/